FINW vs VRTX · P/E 17, rev $92.5M vs P/E 30, rev $3.33B
Finwise Bancorp (FINW) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Finwise Bancorp (FINW) is a banks - regional company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported FINW revenue for 2025-12-31 was $92.5M. Net income was $16.1M. Revenue was up 24.4% from 2024-12-31 to 2025-12-31. FINW currently screens at market cap $208.7M and trailing P/E 17.4.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
FINW currently screens at market cap $208.7M and trailing P/E 17.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the FINW and VRTX stock pages for the full models.
Not investment advice.